Search Results - "Fassett, Rob"

Retinal Basement Membrane Abnormalities and the Retinopathy of Alport Syndrome by Savige, Judy, Liu, John, DeBuc, Delia Cabrera, Handa, James T, Hageman, Gregory S, Wang, Yan Yan, Parkin, John D, Vote, Brendan, Fassett, Rob, Sarks, Shirley, Colville, Deb

Get full text

A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome by Dagher, Hayat, Buzza, Mark, Colville, Deb, Jones, Colin, Powell, Harley, Fassett, Rob, Wilson, Diane, Agar, John, Savige, Judy

“…Previous series that described phenotypes in carriers of Alport's syndrome did not distinguish genetically between carriers of X-linked and autosomal recessive…”
Get full text

No relationship between low-density lipoproteins and endothelial function in hemodialysis patients by Dalton, Brad S., Fassett, Rob G., Geraghty, Dominic P., De Ryke, Rex, Coombes, Jeff S.

“…Background: Relationships between low-density lipoprotein cholesterol and endothelial function in hemodialysis patients have yet to be investigated…”
Get full text

Homocysteine and cardiovascular disease in renal disease by AUSTEN, Simon K, COOMBES, Jeff S, FASSETT, Rob G

“…Elevated homocysteine (hyperhomocysteinaemia) in renal patients is a major concern for physicians. Although cause and effect between homocysteine and…”
Get full text

A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial by Brigandi, Richard A., MD, PhD, Johnson, Brendan, PhD, Oei, Coreen, PhD, Westerman, Mark, PhD, Olbina, Gordana, PhD, de Zoysa, Janak, MBChB, Roger, Simon D., MD, Sahay, Manisha, MD, DNB, Cross, Nicholas, MBChB, MM, PhD, McMahon, Lawrence, MD, Guptha, Veerabhadra, MD, Smolyarchuk, Elena A., MD, Singh, Narinder, MD, Russ, Steven F., MPH, Kumar, Sanjay, PhD

“…Background Anemia associated with chronic kidney disease (CKD) often requires treatment with recombinant human erythropoietin (EPO). Hypoxia-inducible…”
Get full text

Retinal basement membrane abnormalities and the retinopathy of Alport syndrome by Savige, Judy, Liu, John, DeBuc, Delia Cabrera, Handa, James T, Hageman, Gregory S, Wang, Yan Yan, Parkin, John D, Vote, Brendan, Fassett, Rob, Sarks, Shirley, Colville, Deb

“…To determine the effects of X-linked and autosomal recessive Alport syndrome on retinal basement membranes and how these result in the characteristic…”
Get full text

A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial by Johnson, David W., MBBS, DMed (Res), PhD, Pascoe, Elaine M., BSc, MBiostat, Badve, Sunil V., MBBS, MD, Dalziel, Kim, BHealthSc, MHealthEcon, PhD, Cass, Alan, MBBS, PhD, Clarke, Philip, BEc, MEc, PhD, Ferrari, Paolo, MD, McDonald, Stephen P., MBBS, PhD, Morrish, Alicia T., BSc, MPH, Pedagogos, Eugenie, MBBS, PhD, Perkovic, Vlado, MBBS, PhD, Reidlinger, Donna, BA, BAppSc, MPH, Scaria, Anish, BSc, MSc, Walker, Rowan, MD, MPH, Vergara, Liza A., MSc, PhD, Hawley, Carmel M., MBBS, MMedSci

“…Background Erythropoiesis-stimulating agent (ESA)-hyporesponsive anemia is common in chronic kidney disease (CKD). Pentoxifylline shows promise as a treatment…”
Get full text

Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome by Shaw, Elizabeth A., Colville, Deb, Wang, Yan Yan, Zhang, Ke Wei, Dagher, Hayat, Fassett, Rob, Guymer, Robyn, Savige, Judy

“…Background. Alport syndrome is an inherited disease resulting in kidney failure, hearing loss and ocular abnormalities. Alport syndrome is however often…”
Get full text

Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome by Dagher, Hayat, Yan Wang, Yan, Fassett, Rob, Savige, Judy

“…Autosomal recessive Alport syndrome is caused by mutations in the COL4A3 and COL4A4 genes which code for the α3 and α4 chains of type IV collagen. These…”
Get full text

Association between Serum Alkaline Phosphatase and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial by Badve, Sunil V., Zhang, Lei, Coombes, Jeff S., Pascoe, Elaine M., Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., Johnson, David W.

“…Background: Erythropoiesis stimulating agent (ESA)-resistant anemia is common in chronic kidney disease (CKD). Objectives: To evaluate the determinants of…”
Get full text

Integrated critical care: an approach to specialist cover for critical care in the rural setting by Hore, Craig T, Lancashire, William, Roberts, John B, Fassett, Rob

“…Critical care encompasses elements of emergency medicine, anaesthesia, intensive care, acute internal medicine, postsurgical care, trauma management, and…”
Get full text

Homocysteine and cardiovascular disease in renal disease: Review Article by AUSTEN, Simon K, COOMBES, Jeff S, FASSETT, Rob G

“…Elevated homocysteine (hyperhomocysteinaemia) in renal patients is a major concern for physicians. Although cause and effect between homocysteine and…”
Get full text

The Relationship Between Antioxidant Supplements and Oxidative Stress in Renal Transplant Recipients: A Review by Blackhall, Melanie L, Coombes, Jeff S, Fassett, Rob

“…Renal transplant recipients (RTRs) have elevated oxidative stress and a high incidence of cardiovascular morbidity and mortality. Although recent studies do…”
Get full text